Mizagliflozin for low blood sugar after gastric bypass
This study tests a medication called mizagliflozin to help people who have low blood sugar after gastric bypass surgery. It may reduce the number of low blood sugar episodes and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and had Roux-en-Y gastric bypass surgery more than a year ago.
- You have had low blood sugar symptoms with blood sugar below 54 mg/dL, and symptoms improve when you eat or drink sugar.
- You are willing to track your blood sugar and follow study procedures.
- If you are able to have children, you must agree to use birth control during the study.
- You must have at least 4 low blood sugar episodes during a 3-week monitoring period before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new way of using glucose monitoring can help manage low blood sugar that happens after meals in people who have had gastric bypass surgery. It aims to find better ways to track and treat these episodes.
This trial tests whether a diabetes medication called dapagliflozin helps smooth out blood sugar swings after bariatric (weight-loss) surgery. It may help people with type 2 diabetes achieve better control after their surgery.
This early study looks at a gut hormone–based treatment (GLP-1) and how it affects blood sugar and digestion after gastric bypass. It may help people who are having repeated low blood sugar episodes after surgery.
This study looks at how the hormone glucagon affects blood sugar in people who have had gastric bypass or sleeve gastrectomy surgery more than a year ago, compared to people who have not had any gastrointestinal surgery. It aims to understand glucose metabolism better and may help improve care for people after bariatric surgery.
This early-phase study looks at how the body’s hormone signals and nerve control affect insulin release after gastric bypass surgery. It may help researchers understand what drives low blood sugar and how to better monitor or treat it.
This study looks at how food moves through the body and how that may affect episodes of low blood sugar caused by too much insulin. It may help researchers better understand and possibly improve care for people who get hypoglycemia, especially after bariatric (weight-loss) surgery.
Hear when a new Postbariatric Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.